Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs ; volume:48 ; number:01 ; year:2015 ; pages:1-6
Pharmacopsychiatry ; 48, Heft 01 (2015), 1-6
- Beteiligte Personen und Organisationen
-
La Torre, A.
Giupponi, G.
Duffy, D.
Conca, A.
Catanzariti, D.
- DOI
-
10.1055/s-0034-1395515
- URN
-
urn:nbn:de:101:1-2019011107591736360905
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- La Torre, A.
- Giupponi, G.
- Duffy, D.
- Conca, A.
- Catanzariti, D.
Ähnliche Objekte (12)
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Repurposing of approved cardiovascular drugs
Cardiovascular drugs and therapy : CDT
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery
Drugs compromising male sexual health : [with CD-ROM]
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Repurposing of approved cardiovascular drugs
Cardiovascular drugs and therapy : CDT
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery
Drugs compromising male sexual health : [with CD-ROM]
Drug treatment of sexual dysfunction
Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review – Part I: Antidepressants
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review Part II: Antipsychotics
Repurposing of approved cardiovascular drugs
Cardiovascular drugs and therapy : CDT
American journal of cardiovascular drugs : drugs, devices and other interventions
Drug–Drug, Drug–Disease and Disease–Disease Interactions in COVID-19 with Cardiovascular Diseases (CVDs)
Pharmaceuticals, Vol. 1.. Introduction; Cardiovascular drugs
Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
The Grand Challenges in Cardiovascular Drug Delivery